HERON THERAPEUTICS, INC. /DE/ Quarterly Operating Lease, Liability, Noncurrent in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Heron Therapeutics, Inc. /De/ quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q1 2019 to Q2 2024.
  • Heron Therapeutics, Inc. /De/ Operating Lease, Liability, Noncurrent for the quarter ending June 30, 2024 was $1.29M, a 69% decline year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.29M -$2.87M -69% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $2.05M -$2.79M -57.7% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $2.8M -$2.7M -49.1% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $3.54M -$2.61M -42.5% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $4.16M -$2.62M -38.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $4.83M -$2.56M -34.6% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.5M -$2.5M -31.2% Dec 31, 2022 10-K 2024-03-12
Q3 2022 $6.15M -$6.07M -49.7% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $6.78M -$6.23M -47.9% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $7.39M -$6.4M -46.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $8M -$6.57M -45.1% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $12.2M -$3.08M -20.1% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $13M -$3M -18.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $13.8M -$2.92M -17.5% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $14.6M +$2.32M +18.9% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $15.3M +$4.52M +41.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $16M +$4.76M +42.3% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $16.7M +$4.99M +42.5% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $12.2M Dec 31, 2019 10-K 2021-02-24
Q3 2019 $10.8M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $11.3M Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $11.7M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.